Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT

Background: VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such as ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with thrombocytopenia, elevated D-dimer, and pathologic platelet factor 4 anti...

Full description

Saved in:
Bibliographic Details
Main Authors: Hannah Stevens, James D. McFadyen, Natalie A. Mellett, David J. Lynn, Thy Duong, Corey Giles, Jane James, Rochelle Botten, Georgina Eden, Miriam Lynn, Paul Monagle, Peter J. Meikle, Sanjeev Chunilal, Karlheinz Peter, Huyen Tran
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2475037925000019
Tags: Add Tag
No Tags, Be the first to tag this record!